Drug Profile
ALM 12734
Alternative Names: ADP-12734; ALM-12734Latest Information Update: 28 Dec 2021
Price :
$50
*
At a glance
- Originator Almirall S.A.
- Class Antipsoriatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Psoriasis
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for research development in Psoriasis in Spain
- 06 Nov 2017 Early research in Psoriasis in Spain (unspecified route)